Global Anaphylaxis Market Overview: Trends Shaping Growth to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Anaphylaxis Industry Expected To Reach By 2029, Starting From 2025 Levels?

The anaphylaxis market has experienced robust growth recently. It is set to increase from $3.24 billion in 2024 to $3.5 billion by 2025, reflecting a compound annual growth rate (CAGR) of 8.1%. This historical expansion can be attributed to several factors including the rising incidence of food allergies, enhanced awareness regarding anaphylaxis, the development of healthcare infrastructure, advancements in diagnosis and management, and the wider availability of epinephrine auto-injectors.

The anaphylaxis market size is projected to experience robust expansion in the coming years. It is anticipated to reach $4.78 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.1%. This projected growth can be ascribed to factors such as increasing urbanization and evolving lifestyle patterns, a rising frequency of anaphylaxis incidents, escalating disposable incomes in nascent markets, governmental investment in allergy research, and advancements in emergency treatment delivery methods. Significant trends identified for the forecast period include a heightened demand for injectable auto-injectors, the integration of digital health technologies into anaphylaxis management, an intensified focus on making products more affordable, an increase in preventative therapies and vaccines, and a broader application of biologics for allergy treatment.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21096&type=smp

Which Factors And Drivers Are Influencing The Anaphylaxis Market In 2025?

The increasing occurrence of food allergies is projected to drive the expansion of the anaphylaxis market in the future. These allergies represent immune responses provoked by specific foods, manifesting symptoms from minor discomfort to critical conditions, such as severe anaphylaxis. This increase in food allergy cases is attributed to evolving dietary practices, environmental factors, and enhanced diagnostic capabilities coupled with greater public awareness. Crucially, treatment for anaphylaxis offers vital, life-saving aid to individuals with food allergies by quickly reversing intense allergic responses, alleviating issues like swelling, breathing difficulties, and decreased blood pressure. This ensures prompt stabilization, averts potentially deadly situations, and equips patients to respond swiftly to subsequent allergic events. For example, in September 2024, global figures from the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, indicated that approximately 220 million people worldwide suffer from food allergies. It is common for one food item to contain several allergens, and individuals often experience allergic reactions to multiple types of food. Moreover, data from May 2024, detailed in the Patterns and Prevalence of Adult Food Allergy (PAFA) report by the Food Standards Agency (FSA), a UK-based non-ministerial department, revealed that over 30% of adults reported experiencing adverse reactions to food. Clinical evaluations subsequently verified food allergies in about 6% of UK adults, amounting to around 2.4 million people. Consequently, the increasing prevalence of food allergies is indeed fueling the expansion of the anaphylaxis market.

What Are The Leading Segments Analyzed In The Anaphylaxis Market?

The anaphylaxismarket covered in this report is segmented –

1) By Drug Class: Epinephrine; Steroids; Antihistamines; Beta-antagonists; Other Drug Class

2) By Route Of Administration: Parenteral; Oral; Other Routes Of Administration

3) By Application: Food Allergy; Pollen Allergy; Dust Mites Allergy; Other Applications

Subsegments:

1) By Epinephrine: Auto-injectors; Prefilled Syringes; Vials

2) By Steroids: Corticosteroids; Glucocorticoids; Mineralocorticoids

3) By Antihistamines: H1-receptor Antagonists; H2-receptor Antagonists

4) By Beta-antagonists: Selective Beta-blockers; Non-selective Beta-blockers

5) By Other Drug Class: Leukotriene Receptor Antagonists; Mast Cell Stabilizers

What Are The Latest Industry Trends Transforming The Anaphylaxis Market?

Leading companies in the anaphylaxis market are concentrating on developing advanced epinephrine nasal sprays, which enable quicker, more efficient drug delivery during emergencies. An epinephrine nasal spray is a medical device that delivers epinephrine (adrenaline) through the nasal passages as a treatment for severe allergic reactions, including anaphylaxis. For instance, in August 2024, ARS Pharmaceuticals, a US-based biotechnology company, announced Neffy (epinephrine nasal spray) received approval from the Food and Drug Administration, a US-based government agency, positioning it as the first and only needle-free treatment for type I allergic reactions, including anaphylaxis. This innovative nasal spray offers a non-invasive alternative to traditional epinephrine autoinjectors, potentially making emergency treatment more accessible. Neffy aims to boost patient compliance by eliminating the need for needles while providing rapid, life-saving epinephrine during severe allergic reactions.

Which Global Market Leaders Are Shaping The Future Of The Anaphylaxis Sector?

Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

Which Region Currently Holds The Largest Share Of The Anaphylaxis Market?

North America was the largest region in the anaphylaxis market in 2024. The regions covered in the anaphylaxis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Anaphylaxis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21096&type=smp

Browse Through More Reports Similar to the Global Anaphylaxis Market 2025, By The Business Research Company

Anaphylaxis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anaphylaxis-treatment-global-market-report

Allergic Rhinitis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-global-market-report

Animal Antibiotics And Antimicrobials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-antibiotics-and-antimicrobials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795